IR
Superintel
Overview
Markets
Watchlist
More
Rexahn Pharmaceuticals Inc
CUSIP: 761640950 | 1 institutional holders
Watch
Quarters
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
All
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile